VINEETLAB.NS
Vineet Laboratories Limited [VINEETLAB.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VINEETLAB.NS Stock Summary
Top 10 Correlated ETFs
VINEETLAB.NS
Top 10 Correlated Stocks
VINEETLAB.NS
In the News
VINEETLAB.NS Financial details
Company Rating
Neutral
Market Cap
504.74M
Income
26.51M
Revenue
1.71B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
72
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
11.41
Forward P/E
-
PEG
-1.9
P/S
0.34
P/B
2
P/C
-
P/FCF
-66.82
Quick Ratio
0.6
Current Ratio
1.18
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.87
EPS next Y
-
EPS next Q
-
EPS this Y
-81.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-24.73%
EPS Q/Q
-185.5%
-
-
-
-
SMA20
7.69%
SMA50
-23.29%
SMA100
-13.85%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
19%
ROC
0.24%
Gross Margin
21%
Oper. Margin
5%
Profit Margin
3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
44.65-88.9
52W High
-41.42%
52W Low
+17.16%
RSI
44
Rel Volume
0.32
Avg Volume
17.16K
Volume
5.42K
Perf Week
-13%
Perf Month
-3.46%
Perf Quarter
1.18%
Perf Half Y
-0.29%
-
-
-
-
Beta
-0.319
-
-
Volatility
2.18%, 3.47%
Prev Close
-2%
Price
51.55
Change
-2%
VINEETLAB.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 264.11 | 207.37 | 230.28 | |
| Net income per share | 0 | -0.27 | 1.93 | 7.2 | 1.36 | |
| Operating cash flow per share | 0 | 0 | -9.45 | 8.37 | -10.43 | |
| Free cash flow per share | 0 | 0 | -9.45 | 8.37 | -18.71 | |
| Cash per share | 0.01 | 0.09 | 2.28 | 19.65 | 1.06 | |
| Book value per share | 0.44 | 9.73 | 28.87 | 36.03 | 36.54 | |
| Tangible book value per share | 0.44 | 9.73 | 28.87 | 36.03 | 36.54 | |
| Share holders equity per share | 0.44 | 9.73 | 28.87 | 36.03 | 36.54 | |
| Interest debt per share | 0 | 0 | 22.2 | 35.58 | 37.39 | |
| Market cap | 425.92M | 18.94M | 425.92M | 439.29M | 381.67M | |
| Enterprise value | 425.85M | 18.9M | 602.48M | 579.73M | 686.25M | |
| P/E ratio | 0 | -170.62 | 23.92 | 6.62 | 30.47 | |
| Price to sales ratio | 0 | 0 | 0.17 | 0.23 | 0.18 | |
| POCF ratio | 0 | 0 | -4.89 | 5.69 | -3.97 | |
| PFCF ratio | 0 | 0 | -4.89 | 5.69 | -2.21 | |
| P/B Ratio | 103.88 | 4.75 | 1.6 | 1.32 | 1.13 | |
| PTB ratio | 103.88 | 4.75 | 1.6 | 1.32 | 1.13 | |
| EV to sales | 0 | 0 | 0.25 | 0.3 | 0.32 | |
| Enterprise value over EBITDA | 0 | -170.27 | 7.61 | 4.31 | 8.82 | |
| EV to operating cash flow | 0 | 0 | -6.92 | 7.51 | -7.14 | |
| EV to free cash flow | 0 | 0 | -6.92 | 7.51 | -3.98 | |
| Earnings yield | 0 | -0.01 | 0.04 | 0.15 | 0.03 | |
| Free cash flow yield | 0 | 0 | -0.2 | 0.18 | -0.45 | |
| Debt to equity | 0 | 0 | 0.69 | 0.92 | 0.92 | |
| Debt to assets | 0 | 0 | 0.17 | 0.23 | 0.27 | |
| Net debt to EBITDA | 0 | 0.35 | 2.23 | 1.04 | 3.91 | |
| Current ratio | 55.83 | 998.25 | 1.16 | 1.08 | 1.17 | |
| Interest coverage | 0 | 0 | 2.97 | 5.35 | 1.6 | |
| Income quality | 0 | 0 | -2.15 | 0.83 | -4.74 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.02 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0.74 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.79 | |
| Capex to revenue | 0 | 0 | 0 | 0 | -0.04 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | -3.22 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 7.7 | 35.42 | 76.41 | 33.42 | |
| ROIC | 0 | -0.03 | 0.06 | 0.12 | 0.05 | |
| Return on tangible assets | 0 | -0.03 | 0.02 | 0.05 | 0.01 | |
| Graham Net | 0 | 0.08 | -29.02 | -36.2 | -34.42 | |
| Working capital | 4.1M | 3.99M | 117.12M | 76.46M | 129.53M | |
| Tangible asset value | 4.1M | 3.99M | 266.15M | 336.95M | 336.83M | |
| Net current asset value | 4.1M | 3.99M | 42.36M | 23.17M | 52.97M | |
| Invested capital | 0 | 0 | 0.69 | 0.92 | 0.92 | |
| Average receivables | 0 | 0 | 222.88M | 403.87M | 356.81M | |
| Average payables | 68.63K | 37.39K | 279.94M | 580.4M | 474.93M | |
| Average inventory | 0 | 0 | 198.43M | 416.13M | 448.57M | |
| Days sales outstanding | 0 | 0 | 66.82 | 69.11 | 60.46 | |
| Days payables outstanding | 0 | 0 | 101.13 | 150.49 | 73.91 | |
| Days of inventory on hand | 0 | 0 | 71.68 | 109.04 | 97.8 | |
| Receivables turnover | 0 | 0 | 5.46 | 5.28 | 6.04 | |
| Payables turnover | 0 | 0 | 3.61 | 2.43 | 4.94 | |
| Inventory turnover | 0 | 0 | 5.09 | 3.35 | 3.73 | |
| ROE | 0 | -0.03 | 0.07 | 0.2 | 0.04 | |
| Capex per share | 0 | 0 | 0 | 0 | -8.28 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 72.42 | 62.05 | 40.7 | 47.05 | 35.41 | |
| Net income per share | 1.51 | 3.85 | -1.36 | 2.62 | -2.24 | |
| Operating cash flow per share | 0 | 1.34 | 1.32 | 1.33 | 1.36 | |
| Free cash flow per share | 0 | 1.34 | 1.32 | 1.33 | 1.36 | |
| Cash per share | 1.41 | 1.06 | 1.06 | 1.2 | 0 | |
| Book value per share | 32.54 | 36.54 | 35.18 | 37.81 | 0 | |
| Tangible book value per share | 32.54 | 36.54 | 35.18 | 37.81 | 0 | |
| Share holders equity per share | 32.54 | 36.54 | 35.18 | 37.81 | 0 | |
| Interest debt per share | 35.16 | 34.12 | 34.62 | 45.17 | 1.17 | |
| Market cap | 583.1M | 381.67M | 479.85M | 466.48M | 753.65M | |
| Enterprise value | 887.79M | 686.25M | 782.64M | 866.46M | 753.65M | |
| P/E ratio | 10.47 | 2.69 | -9.6 | 4.82 | -9.12 | |
| Price to sales ratio | 0.87 | 0.67 | 1.28 | 1.08 | 2.31 | |
| POCF ratio | 0 | 30.89 | 39.42 | 38.11 | 60.15 | |
| PFCF ratio | 0 | 30.89 | 39.42 | 38.11 | 60.15 | |
| P/B Ratio | 1.94 | 1.13 | 1.48 | 1.34 | 0 | |
| PTB ratio | 1.94 | 1.13 | 1.48 | 1.34 | 0 | |
| EV to sales | 1.33 | 1.2 | 2.09 | 2 | 2.31 | |
| Enterprise value over EBITDA | 45.44 | 11.75 | 274.44 | 20.72 | -117.48 | |
| EV to operating cash flow | 0 | 55.54 | 64.3 | 70.79 | 60.15 | |
| EV to free cash flow | 0 | 55.54 | 64.3 | 70.79 | 60.15 | |
| Earnings yield | 0.02 | 0.09 | -0.03 | 0.05 | -0.03 | |
| Free cash flow yield | 0 | 0.03 | 0.03 | 0.03 | 0.02 | |
| Debt to equity | 1.05 | 0.92 | 0.95 | 1.17 | 0 | |
| Debt to assets | 0.28 | 0.27 | 0.29 | 0.33 | 0 | |
| Net debt to EBITDA | 15.6 | 5.22 | 106.18 | 9.57 | 0 | |
| Current ratio | 1.15 | 1.17 | 1.19 | 1.18 | 0 | |
| Interest coverage | 1.4 | 14.13 | -0.34 | 3.48 | -1.18 | |
| Income quality | 0 | 0.35 | -0.97 | 0.51 | -0.61 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 33.26 | 56.24 | 32.76 | 47.24 | 0 | |
| ROIC | 0.08 | 0.06 | 0 | 0.04 | 0 | |
| Return on tangible assets | 0.01 | 0.03 | -0.01 | 0.02 | 0 | |
| Graham Net | -40.24 | -34.42 | -30.47 | -31.79 | 0 | |
| Working capital | 108.26M | 129.53M | 129.88M | 140.82M | 0 | |
| Tangible asset value | 300.01M | 336.83M | 324.33M | 348.52M | 0 | |
| Net current asset value | 20.75M | 52.97M | 44.85M | 68.92M | 0 | |
| Invested capital | 1.05 | 0.92 | 0.95 | 1.17 | 0 | |
| Average receivables | 266.65M | 297.82M | 352.19M | 409.44M | 233.06M | |
| Average payables | 466.68M | 398.74M | 373.47M | 407.77M | 208.78M | |
| Average inventory | 494.15M | 475.54M | 434.33M | 421.07M | 217.61M | |
| Days sales outstanding | 32.89 | 55.33 | 84.61 | 96.72 | 0 | |
| Days payables outstanding | 68.15 | 76.83 | 116.35 | 123.48 | 0 | |
| Days of inventory on hand | 74.35 | 101.67 | 118.96 | 128.7 | 0 | |
| Receivables turnover | 2.74 | 1.63 | 1.06 | 0.93 | 0 | |
| Payables turnover | 1.32 | 1.17 | 0.77 | 0.73 | 0 | |
| Inventory turnover | 1.21 | 0.89 | 0.76 | 0.7 | 0 | |
| ROE | 0.05 | 0.11 | -0.04 | 0.07 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
VINEETLAB.NS Frequently Asked Questions
What is Vineet Laboratories Limited stock symbol ?
Vineet Laboratories Limited is a IN stock and trading under the symbol VINEETLAB.NS
What is Vineet Laboratories Limited stock quote today ?
Vineet Laboratories Limited stock price is $51.55 today.
Is Vineet Laboratories Limited stock public?
Yes, Vineet Laboratories Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 17.16K
- Market Capitalization 504.74M
- Employee 72
- CEO Mr. Satish Pandurang Samant
- Headquarters Hyderabad,IN
- IPO Date 2021-06-15
-
Website
https://vineetlabs.co.in 
Vineet Laboratories Limited engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals in India. The company was incorporated in 2016 and is based in Hyderabad, India.
